Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-15

Clinical Trial Update: Study of Tirzepatide for Recovery and Alcohol Use Management [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tirzepatide for recovery and management of alcohol use disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (Zepbound) (tirzepatide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Alcohol Use Disorder (AUD) | Phase 2 | Status: RECRUITING